←Back to Expert Scholars
Translational Medicine / 转化医学Head and Neck Cancer
Barbara Burtness
MD
🏢Yale School of Medicine🌐USA
Professor of Medicine, Medical Oncology
85
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Barbara Burtness led KEYNOTE-048 establishing pembrolizumab with or without chemotherapy as first-line standard treatment for recurrent metastatic head and neck squamous cell carcinoma. She is one of the most influential head and neck medical oncologists globally.
Share:
🧪Research Fields 研究领域
KEYNOTE-048
pembrolizumab head and neck
recurrent metastatic HNSCC
EGFR therapy
HPV-associated cancer
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Barbara Burtness 的研究动态
Follow Barbara Burtness's research updates
留下邮箱，当我们发布与 Barbara Burtness（Yale School of Medicine）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment